# Business Use Case: AI Pharmacovigilance & Safety Signal Intelligence Platform

## 1. Executive Summary
Pharmacovigilance (PV) and drug safety departments face exponential growth in adverse event (AE) reports from clinical trials, spontaneous post-marketing surveillance, patient registries, and biomedical literature. Processing individual safety cases (ICSRs), extracting entities (suspect drugs, adverse reactions, concomitant medications), and detecting disproportionality signals (such as unexpected liver injury or cardiac arrhythmias) manually creates massive backlogs and compliance risks with health authorities (FDA, EMA).

This platform acts as an **AI-driven safety triage and signal detection copilot**:
1. **Automated AE Entity Extraction**: Extracts suspect drugs, reaction terms (MedDRA-style), severity, and patient outcomes from unstructured narratives using Presidio PII scrubbing and LLM extraction.
2. **Deterministic Statistical Signal Detection**: Computes Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) metrics to detect emerging drug-event pairs without hallucination.
3. **Hybrid RAG Literature & Label Retrieval**: Retrieves evidence from medical literature and product package inserts.
4. **Investigator Workflow & Decision Audit**: Multi-agent summaries prepared for safety physicians with mandatory human sign-off (`SAFETY_REVIEWER`).

---

## 2. Target Industry & Organizations
- **Therapeutic Focus**: Global Pharmacovigilance, Patient Safety, Regulatory Risk Management.
- **Target Organizations**: Post-Marketing Safety Divisions, Global Biopharma Enterprises, and Contract Safety Organizations.

---

## 3. Current State vs. Target State

| Dimension | Current State (Manual Drug Safety) | Target State (AI Pharmacovigilance Platform) |
| :--- | :--- | :--- |
| **Case Intake & Extraction** | Safety analysts spend 45–60 minutes manually transcribing unstructured narrative PDFs into database fields. | Automated extraction of MedDRA terms, suspect drugs, and patient demographics in seconds with side-by-side verification. |
| **Signal Detection** | Batch statistical reports run quarterly; emerging safety signals may go unnoticed for months. | Real-time statistical PRR/ROR calculation over incoming case streams with automated threshold alerts. |
| **Evidence Gathering** | Safety reviewers spend days pulling product label sections, prior case precedents, and PubMed abstracts. | Integrated RAG engine linking the drug-event signal directly to package labels and indexed scientific papers. |
| **Regulatory Auditability** | Difficult to reconstruct why a particular safety signal was investigated or closed. | Immutable decision trail capturing the reviewer identity, timestamp, rationale, and exact evidence snapshot. |

---

## 4. Primary Personas & User Journeys

### Persona A: Drug Safety Case Analyst
- **Pain Point**: "I have 50 spontaneous adverse event narratives to process today. Extracting every symptom, date, and dosage is repetitive and prone to typographical errors."
- **User Journey**:
  1. Uploads case narrative text.
  2. Presidio scrubs patient PII (names, phone numbers).
  3. System parses suspect drugs (`CardioShield`), reaction (`Acute Hepatitis`), severity (`Serious - Hospitalization`).
  4. Analyst confirms extracted entities with one click; record is persisted.

### Persona B: Pharmacovigilance Physician / Safety Investigator
- **Pain Point**: "Did the signal for CardioShield and Acute Hepatitis cross the statistical PRR significance threshold? What is known from our product label?"
- **User Journey**:
  1. Opens **Safety Signal Dashboard**.
  2. Inspects signal `CardioShield <-> Acute Hepatitis`:
     - Observed Cases: 24 | Expected: 6.2
     - PRR: 3.87 (Threshold > 2.0, Chi-Square: 18.4)
  3. Inspects **Evidence Drawer**:
     - Product Label: "Hepatotoxicity mentioned in Section 5.1 as Rare (<0.1%)".
     - Literature: 2 recent case reports describing similar onset within 14 days.
  4. Reviews AI-synthesized clinical briefing from Sarvam AI.
  5. Selects action: `Escalate to Safety Committee for Label Update` with mandatory justification notes.
  6. Audit event is permanently sealed in the database.

---

## 5. Agentic AI & NL2SQL Architecture

- **Safe NL2SQL**: Enables safety officers to query longitudinal databases in natural language:
  *"Find all serious cases reported in females aged 40-60 for CardioShield where hospital stay exceeded 5 days."*
- **LangGraph Multi-Agent Team**:
  - `Case Extraction Agent`: Extracts structured clinical entities.
  - `Statistical Signal Agent`: Runs deterministic mathematical formulas for PRR, ROR, and Chi-square.
  - `Literature & Label Retrieval Agent`: Searches pgvector chunks for relevant publications.
  - `Safety Summary Agent`: Synthesizes evidence into a neutral briefing without making autonomous medical diagnoses.
  - `Human Investigator Gate`: Requires safety reviewer sign-off.

---

## 6. Measurable Business KPIs & Financial ROI

- **Case Intake Efficiency**: 50% reduction in first-pass ICSR case processing time.
- **Signal Discovery Latency**: Shortens time-to-detect emerging safety signals from 90 days to real-time.
- **Regulatory Compliance**: Zero late-reporting penalties by automating 15-day expedited reporting triage.
